The following text comes from this article: https://friedreichsataxianews.com/2017/03/16/study-cells-friedreichs-ataxia/ “The selective degeneration of certain neurons in patients with Friedreich’s ataxia may be explained by the effect that the lack of frataxin has on nervous system cells called astrocytes. Researchers discovered that mice, which grew up without frataxin, had abnormal astrocytes in their cerebellum,...

The team of Dr. Jacques P. Tremblay (Research Center of the CHU of Quebec – Université Laval) is continuing his research to develop a treatment for Friedreich’s Ataxia. Dr. Tremblay’s team recently obtained a grant from Ataxia Canada to develop a new AAV serotype capable of infecting the brain and...

Ataxia Canada has agreed to fund a research project of Dr. Antoine Duquette which consists of testing some biological markers. We believe this project could make a significant contribution to future clinical trials of a Friedreich’s ataxia treatment. It is therefore a project for which we will recruit 25 patients...

Application deadline: October 28, 2016  Dear Ataxia Canada members, During the General Meeting on November 13 2016, we will elect four (4) members on the Board of the Association. We are looking for nominations satisfying the following criterias: -be registered as a member of the Foundation; -be involved in the...